3B Future Health Fund

3i Group plc

AATec Medical GmbH

AbbVie Ventures

AbbVie, Inc.

abcDNA GmbH

Abingworth LLP

Abivax SA

Accequa

AdBio Partners

AdCab

ADOCIA

Adularia AG

Advantary Capital Partners

AEC Partners

AFK & Partners Asset Management LLC

Aixial Group

Akribion Therapeutics GmbH

Alipheron AG

Allegro N.V.

Alternative Assets Finance

Altrovia

Alzinova AB

Ampleia

Amporin Pharmaceuticals AG

AMR Action Fund GP GmbH

Anaveon AG

Andera Partners SA

Angelini Ventures S.p.A.

Apollo Health Ventures

ARCHIMED

Argenx

Argobio Studio

Asahi Kasei Europe GmbH

Astellas Pharma Europe Ltd.

AstraZeneca

Astrivax Therapeutics N.V.

ATGN Consulting

Atlas Capital Ventures LLC

AudioCure Pharma GmbH

Aukera Therapeutics GmbH

AurorA Science Srl

Avance Life Sciences

Awen GmbH

Baker McKenzie

BaseLaunch

Bayer Pakistan Limited

Bayern Kapital GmbH

BB Biotech AG

BeOne Medicines I GmbH

Bergaud & Partners

BERNINA BioInvest Ltd.

Bio Med Gene Ventures

BioMedPartners AG

BiomedVC AG

BioPharma Advisory

Bioqube Ventures

BIOSTART Consulting GmbH

biotx.ai GmbH

Biovision Ventures

Bioxodes SA

BlackRock

Blackstone Group

Bloomberg Intelligence

Bloomberg LP

BNP Paribas Asset Management

Boehringer Ingelheim International GmbH

Borea Therapeutics S.r.l.

Bpifrance

Brainomix Limited

Brandon Capital Partners

Breakline Resolution

Brenus Pharma

Breslin AG

Breslin AG - LSFA

BSM Biotech Holding GmbH

Business Angels Switzerland

Caedo Oncology AS

Caladrix Pty Ltd

Cancer Research Horizons

Canton of Basel-Stadt

Capital Grand Est

CARTemis Therapeutics GmbH

Cati Therapeutics

CB Therapeutics

CD4 Therapeutics GmbH

CDR-Life, Inc.

Cereus Biosciences

CervoMed, Inc.

CheckBrain Therapeutics

Chugai Venture Fund, LLC

Claris Ventures

ClearideBio Therapeutics AG

Cohesion Bureau

Connext Co., Ltd.

Convergence Partners

Corinthian Financial Management Ltd

Coulter Partners

Covington & Burling LLP

CPTx GmbH

CureGBM

Curlim

Cytovation ASA

DeBere Partners Limited

Debiopharm International SA

Dementia Discovery Fund 2 L.P. (SV Health Investors)

Diamante Società Benefit Srl

Digital Networks PLC

Earlybird Health Management GmbH & Co. KG

Eight Bridges

Eleva GmbH

Eli Lilly and Company

Ervimmune

ESC Advisors

European Braintech Fund

European Investment Bank

European Investment Fund

Evernow Publishing Ltd, publisher of MedNous

Evidenze

Evotec AG

Expert Systems, Inc.

ExpreS2ion Biotech Holding AB

F. Hoffmann-La Roche AG

FastVentures B.V.

FimmCyte AG

Finanz und Wirtschaft

Fine Treatment Limited

FINNCURE Ltd.

FluoSphera SA

Fontaine Capital

Forbion

Forta Bio, Inc.

Fortlane Partners GmbH

Forty51 Ventures AG

Forvis Mazars

Fraser Partners

FreeMind Group

Fresenius Ventures

Fund+

Futurewave AG

Galimedix Therapeutics, Inc.

Generation Fund Life Sciences Fund I

Genevant Sciences GmbH

Genius Search GmbH & Co. KG

Genmab A/S

Gero Pte. Ltd

Gibela Therapeutics GmbH

GIBF

Gilde Healthcare Partners BV

Gimv

Global Close Alliances Ltd.

GOLDTRACK Ventures GmbH

GSK

Gubra Ventures

Gyre Therapeutics, Inc.

Hadean Ventures

Hansa Biopharma AB

HealthCap

HealthCare Royalty Partners

HeartBeat.bio AG

Helsinn Healthcare SA

HEPHAISTOS-Pharma

High-Tech Gründerfonds Management GmbH

Hong Kong Exchanges and Clearing Limited (HKEX)

HOX Therapeutics Ltd.

i&i Biotech Fund I SCSp

IAMA Therapeutics S.r.l.

ICF Consult Switzerland

ICOSA Group

Indaco Venture Partners SGR S.p.A.

Industrifonden

InflaRx GmbH

iniuva GmbH

Innovestor Life Science Ltd.

Innunity Therapeutics

INOGROUP GmbH

Institute of Molecular & Clinical Ophthalmology Basel (IOB)

Intercontinental Capital

Intermediate Capital Group PLC

Inveready Asset Management S.G.E.I.C., S.A.

InvestHK

IPF Partners

iQure Pharma Inc.

Italian Angels for Growth (IAG)

IXICO plc

J.P. Morgan

J.P. Morgan Private Bank (Suisse) SA

Jeito Capital

JFG Life Sciences Stiftung der Universität Basel

Johnson & Johnson Innovation LLC

Justin Stindt Consulting AG

Kaleida Capital Management LLC

Kerna Ventures

kez.biosolutions GmbH

KG Capital Management LLC.

KHAN Fund

King Bioventures

Kinled Holding Limited

KreaMedica Holdings Inc.

Ksilink

Kurma Partners

Landmark BioVentures AG

Laverock Therapeutics Ltd.

LifeArc Ventures

LifeCare Partners GmbH

Lifespan Vision Ventures LLC

LIMAA Technologies GmbH

LMU Munich

Loma Therapeutics

LongRiver Investments

Lonza Group AG

Lucera GmbH

Lynx Financial Hong Kong Ltd.

Mabqi S.A.S.

Maeve Therapeutics B.V.

MARATHON Beteiligungs AG

Meddenovo Drug Design SAS

Medicxi

MedinCell S.A.

MEDiSTRAVA

Meliodays Medical GmbH

Merck KGaA

Mérieux Equity Partners

Micreos Pharma

MIG Capital

Mirabaud & Cie SA

Mission BioCapital

Modi Ventures

MONCYTE Health

Move Venture Consulting

Mwyngil Therapeutics

Myria Biosciences AG

Nanolynx Biologics AG

NatIgGs GmbH

Neumirna Therapeutics ApS

Neurimmune AG

NeutroGen Therapeutics GmbH

NG Bio LTD

Nœtica Pharma

Nomal Therapeutics

Novartis BioMedical Research

Novartis Pharma AG

Novo Holdings A/S

Novo Nordisk A/S

NRW.Venture

NRx Pharmaceuticals, Inc.

NS Pharma, Inc.

Nucleome Therapeutics Ltd.

Nucleus Network Ltd

NXI Therapeutics AG

NxR Biotechnologies GmbH

OKG Capital LP

Omega Funds

Oncode Accelerator

Oncostellae

Oppenheimer & Co. Inc.

Organon

Origenis GmbH

Otsuka Pharmaceutical Europe Ltd.

Oxford Science Enterprises plc

OxSonics

Panakès Partners SGR SpA

Panosome GmbH

Parexel International

Partners Group

Peppermint VenturePartners GmbH

Peregrine Ventures

Perseo Pharma AG

Persica Pharmaceuticals Limited

PharmCube

PharmNovo AB

Phialogics AG

Procavea Biotech AG

PSCC

PulseSight Therapeutics SAS

Pureos Bioventures

Rahim Invest SÀRL

Recordati Pharma GmbH

Redalpine Venture Partners AG

Rhea BioVentures

Roche Venture Fund

Ropes & Gray LLP

RV Invest GmbH

Salus Partners SA

Sappiens SAS

Schwarz Financial Communication

SCI Ventures LLC

Secarna Pharmaceuticals GmbH & Co. KG

SEDGE Ventures LLC

Seekyo Therapeutics

Selonterra, Inc.

SEQENS

Serca Pharmaceuticals AS

Serenatis Bio Ltd.

Servier Ventures

Seventure Partners

Shanda Grab Ventures Limited

Sirona Capital

Skyvor Medical AG

Sobi

Sofinnova Partners

Solgate GmbH

SPARK Finland

SpliceBio, S.L.

Staatz BD & Strategy

Stifel

Strategic Transactions Advisory AG

Strike Pharma AB

Sunstone Life Science Ventures

Swiss Biotech Association

SymphoRNA

Synameta Therapeutics

T-CURX GmbH

TargImmune Therapeutics AG

Terra Quantum AG

The Fulford Group Ltd.

Therakles Pharmaceuticals AG

TheraVenture GmbH

TOLREMO Therapeutics AG

Tribune Therapeutics AB

Tridek-One Therapeutics

Truffle Capital

Tuari Therapeutics GmbH

TVM Capital Life Science

UBS AG

UCB Ventures

Umlaut.bio GmbH

Universite Paris-Saclay

University of Zurich

UPyTher B.V.

UZH Life Sciences Fund, AG

VALANX Biotech GmbH

Valor Management

VBW Holdings, LLC

Venture Valuation VV AG

Versant Ventures

Vesalius Biocapital III

Vesalius Biocapital IV Partners SàRL

Vi Partners AG

Viopas Venture Consulting GmbH

Vogel BioC

VS Principal Investments AG

VUS Genetics

Wellington Partners

WG Partners LLP

WuXi AppTec

Xendara Bio

XGEN Venture SGR S.p.A.

Xlife Sciences AG

XOventure

YAYA Capital

YGION Biomedical GmbH

Zinc VC